|
|
| (11) | Number of the document | |
| (68) | Number of the document | 3581650 |
| (21) | Application number for Supplementary Protection Certificate | PA 2023 521 |
| (22) | Date of filing the application | 2023-07-27 |
| (41) | Date of publication of the application | 2023-08-25 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
uniQure biopharma B.V. ,
Paasheuvelweg 25a, 1105 BP Amsterdam,
NL
|
| (73) |
uniQure biopharma B.V. ,
Paasheuvelweg 25a, 1105 BP Amsterdam,
NL
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/22/1715, 2023-02-20 |
| (95) | Etranakogenas dezaparvovekas (adenoasocijuotas virusinis vektorius, turintis pagal kodoną optimizuotą žmogaus krešėjimo faktoriaus IX geno Padua variantą, skirtą hemofilijai B gydyti) |
| SPC application published |